Search

everythinglearnresearchcommunity

for

Search:↓

High levels of androgens during early development may cause PCOS-like symptoms.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Testosterone helps human pancreatic cells increase insulin release.

Menopause-related skin changes may increase fungal infections and inflammation.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Yoga helps manage PCOS symptoms and improves overall health.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

Women with PCOS have a higher risk of heart disease.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hair loss in alopecia areata can negatively affect sexual quality of life.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Finasteride effectively treats baldness but may cause sexual side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.